No increase in prevalence of hepatitis B Surface antigen mutant in a population of children and adolescents who were fully covered by universal infant immunization

Journal of Infectious Diseases

Volumn 201, Issue 8, 2010, Pages 1192-1200

  Hsu, Hong Yuan ^a,b   Chang, Mei Hwei ^a   Ni, Yen Hsuan ^a   Chiang, Cheng Lun ^a,b   Chen, Huey Ling ^a,b   Wu, Jia Feng ^a   Chen, Pei Jer ^c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b Department of Primary Care Medicine ^*  (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; RECOMBINANT VACCINE; VIRUS DNA;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; GENOTYPE; HEALTH SURVEY; HEPATITIS B VIRUS; HUMAN; IMMUNIZATION; INFANT; MAJOR CLINICAL STUDY; NEWBORN; PEDIATRICS; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; WILD TYPE;

EID: 84984550744     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/651378     Document Type: Article

References (30)

1. Howard CR, Allison LM. Hepatitis B surface antigen variation and protective immunity. Intervirology 1995;38:35-40.
2. Waters JA, O'Rourke SM, Richardson SC, Papavengelo G, Thomas HC. Quantitative analysis of the humoral immune response to the "a" determinant of HBs antigen after inoculation with plasma derived or recombinant vaccine. J Med Virol 1987;21:155-160.
3. Carman WF, Van Deursen FJ, Mimms LT, et al. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia. Hepatology 1997;26:1658-1666.
4. Hsu HM, Lu CF, Lee SC, Lin SR, Chen DS. Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass vaccination. J Infect Dis 1999;179:367-370.
5. Carman WF, Zanetti AR, Karayiannis P, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990;336:325-329.
6. Fortuin M, Karthigesu V, Allison L, et al. Breakthrough infections and identification of a novel variant in Gambian children immunized with hepatitis B vaccine. J Infect Dis 1994;169:1374-1376.
7. Karthigesu VD, Allison LM, Fortuin M, Mendy M., Whittle HC, Howard CR. A novel hepatitis B variant in the sera of immunized children. J Gen Virol 1994;75:443-448.
8. Oon CJ, Lim GK, Ye Z, et al. Molecular epidemiology of hepatitis B vaccine variants in Singapore. Vaccine 1995;13:699-702.
9. Ngui SL, O'Connell S, Eglin RP, Heptonstall J, Teo CG. Low detection rate and maternal provenance of hepatitis B virus S gene mutants in cases of failed postnatal immunoprophylaxis in England and Wales. J Infect Dis 1997;176:1360-1365.
10. Hsu HY, Chang MH, Liaw SH, Ni YH, Chen HL. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 1999;30:1312-1317.
11. Hsu HY, Chang MH, Ni YH, Chen HL. Survey of hepatitis B surface variant infection in children 15 years after nationwide vaccination program in Taiwan. Gut 2004;53:1499-1503.
12. Basuni AA, Butterworth L, Cooksley G, Locamini S, Carman WF. Prevalence of HBsAg mutants and impact of hepatitis B infant immunization in four Pacific Island countries. Vaccine 2004;22:2791-2799.
13. NiYH, Huang LM, Chang MH, et al. Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology 2007;132:1287-1293.
14. Hsu HY, Chang MH, Chen DS, Lee CY, Sung JL. Baseline seroepidemiology of hepatitis B virus infection in Taipei, 1984: a study just before a mass hepatitis B vaccination program in Taiwan. J Med Virol 1986;18:301-307.
15. Tsen YJ, Chang MH, Hsu HY, Lee CY, Sung JL, Chen DS. Seroprevalence of hepatitis B infection in children in Taipei, 1989: five years after a mass hepatitis B vaccination program. J Med Virol 1991;34: 96-99.
16. Chen HL, Chang MH, Ni YH, et al. Seroepidemiology of hepatitis B virus infection in children: ten years after a hepatitis B mass vaccination program in Taiwan. JAMA 1996;276:906-908.
17. Ni YH, Chang MH, Huang LM, et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 2001;135:796-800.
18. Yeh SH, Tsai CY, Kao JH, et al. Combined real-time PCR quantification and signature single nucleotide polymorphism genotyping of hepatitis B virus in one-tube reaction. J Hepatol 2004;41:659-666.
19. Hopp TP, Woods KR. Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci USA 1981;78:3824-3828
20. Hsu HY, Chang MH, Ni YH, Lin HH, Wang SM, Chen DS. Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis. Hepatology 1997;26:786-791.
21. Lin HH, Chang MH, Chen DS, et al. Early predictor of the efficacy of immunoprophylaxis against perinatal hepatitis B transmission: analysis of prophylaxis failure. Vaccine 1991;9:457-460.
22. Nainan OV, Khristova M, Byun K, et al. Genetic variation of hepatitis B surface antigen coding region among infants with chronic hepatitis B virus infection. J Med Virol 2002;68:319-327.
23. Lin HH, Kao JH, Chang TC, Hsu HY, Chen DS. Secular trend of agespecific prevalence of hepatitis B surface and e antigenemia in pregnant woman in Taiwan. J Med Virol 2003;69:466-470.
24. Kalinina T, Iwanski A, Will H, Sterneck M. Deficiency in virion secretion and decreased stability of the hepatitis B virus immune escape mutant G145R. Hepatology 2003;38:1274-1281.
25. Thakur V, Kazim SN, Guptan R, et al. Transmission of G145R mutant of HBV to an unrelated contact. J Med Virol 2005;76:40-46.
26. Magnius LO, Norder H. Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology 1995;38:24-34.
27. Koyanagi T, Nakamuta M, Sakai H, et al. Analysis of HBs antigen negative variant of hepatitis B virus: unique substitutions, Glu129 to Asp and Gly145 to Ala in the surface antigen gene. Med Sci Monit 2000;6:1165-1169.
28. Chen YC, Delbrook K, Dealwis C, Mimms L, Mushawar IK, Manderki W. Discontinuous epitopes of hepatitis B surface antigen derived from a filamentous phage peptide library. Proc Natl Acad Sci U S A 1996; 93:1997-2001.
29. Lelie PN, Ip HMH, Reesnink HW, Wong VCW, Kuhns MC. Prevention of hepatitis B virus carrier state in infants of mothers with high and low serum levels of HBV-DNA. In: Hollinger FB, Lemon SM, Margolis HS, eds. Viral hepatitis and liver disease. Baltimore, MD: Williams 8c Wilkins, 1991:753-756.
30. Maupas P, Chiron JP, Barin F, Coursaget P, Goudeau A. Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Lancet 1981;1:289-292.